Minapharm Pharmaceuticals (Minapharm) reported a 37% Year on Year (YoY) jump in its consolidated net profit during the first quarter
By Staff Writer, Arab Finance
ArabFinance: Minapharm Pharmaceuticals (Minapharm) reported a 37% Year on Year (YoY) jump in its consolidated net profit during the first quarter (Q1) of 2021, the company said in a statement to the Egyptian Exchange.
Consolidated net profit stood at EGP 119.88 million in Q1 2021, compared to EGP 75.25 million in Q1 2020.
The company’s standalone net profit recorded EGP 57.92 million by the end of March, compared to EGP 18.47 million in the same period a year ago.
In 2020, the company logged a consolidated net profit of EGP 300.78 million.
Minapharm Pharmaceuticals is an Egypt-based company engaged in the production and distribution of pharmaceutical products. It is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt.
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
Get Zawya's daily newsletter for insightful and exclusive Middle East perspectives on business and finance. SUBSCRIBE NOW